Genpharmasec (BOM:531592) COGS-to-Revenue : 1.00 (As of Mar. 2025)

View and export this data going back to 1996. Start your Free Trial

What is Genpharmasec COGS-to-Revenue?

Genpharmasec's Cost of Goods Sold for the three months ended in Mar. 2025 was ₹139.6 Mil. Its Revenue for the three months ended in Mar. 2025 was ₹140.1 Mil.

Genpharmasec's COGS to Revenue for the three months ended in Mar. 2025 was 1.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Genpharmasec's Gross Margin % for the three months ended in Mar. 2025 was 0.33%.

Genpharmasec COGS-to-Revenue Historical Data

The historical data trend for Genpharmasec's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpharmasec COGS-to-Revenue Chart

Genpharmasec Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Mar25

COGS-to-Revenue

Get a 7-Day Free Trial

0.92

1.00

0.93

0.80

0.88

Genpharmasec Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
COGS-to-Revenue	Get a 7-Day Free Trial															0.80	0.80	0.83	0.76	1.00

Genpharmasec COGS-to-Revenue Calculation

Genpharmasec's COGS to Revenue for the fiscal year that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	295.486	/	337.218
	=	0.88

Genpharmasec's COGS to Revenue for the quarter that ended in Mar. 2025 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	139.633	/	140.097
	=	1.00

Genpharmasec (BOM:531592) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Genpharmasec's Gross Margin % for the three months ended in Mar. 2025 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	139.633 / 140.097
	=	0.33 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Genpharmasec COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Genpharmasec's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Genpharmasec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genpharmasec Ltd (BOM:531592) » Definitions » COGS-to-Revenue

Traded in Other Exchanges

N/A

Address

Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101

Website

https://www.genpharmasec.com

Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in two reportable segments namely; Diagnostic Pharma Equipment which includes pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, and herbs, and pharmaceutical, medicinal, and proprietary and industrial preparations, compounds, and articles of kinds, chemists, druggists, and chemical manufacturers. The Trading in the Securities segment of the company invests in the secondary securities market. The Diagnostic Pharma Equipment segment is the key revenue generator for the group.

Genpharmasec Headlines

No Headlines